BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
$66.12 1.05 (1.6136%)
Analysed BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) News Sources
BioMarin acquires experimental drug for rare bone disorder in $275M deal
18-08-2026
biopharmadive.com
BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline
18-08-2026
yahoo.com
BioMarin Shares Jump After $275 Million Deal to Acquire Alesta Therapeutics
18-08-2026
advfn.com
BioMarin Pharmaceutical's Alesta Deal Strengthens Long-Term Growth Outlook, Wedbush Says
18-08-2026
yahoo.com
BMRN Stock Rises On Up To $490M Alesta Deal, But Analyst Cuts Price Target To $59 — Here’s Why
18-08-2026
stocktwits.com
BioMarin Inks $490M Deal to Buy Rare Bone Disease Treatment
19-08-2026
yahoo.com
BioMarin spends up to $490m for Alesta’s bone disease candidate
19-08-2026
pharmaceutical-technology.com
BioMarin acquiring Alesta Therapeutics for $275 million
19-08-2026
qz.com
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
19-08-2026
yahoo.com
BioMarin Pharmaceutical (BMRN) Agrees $490 Million Deal For Oral Rare Bone Disease Program
21-08-2026
yahoo.com
What is the current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is $66.12.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is $1.05.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is 1.6136%.
What is the most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is 91 out of 100.
What is the most recent average sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is .
SEC-8K** Filing Available For BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.